27 results on '"Beatrice Scellini"'
Search Results
2. Myocardial overexpression of ANKRD1 causes sinus venosus defects and progressive diastolic dysfunction
- Author
-
Raffaella Cinquetti, Laura Monti, Paola Pesce, Federico Caicci, Ileana Badi, Marina Campione, Roberto Taramelli, Michela Menegollo, Simonetta Ausoni, Francesco Acquati, Stefano Manzini, Beatrice Scellini, David Sacerdoti, Marco Busnelli, Simone Tiso, F. Dellera, Chiara Tesi, Corrado Poggesi, Annalisa Grimaldi, Daniele Bruno, Nicoletta Piroddi, Lucia Manni, Steven B. Bleyl, G.S. Ganzetti, Virginia Cora, and Giulia Chiesa
- Subjects
medicine.medical_specialty ,ANKRD1 ,Sinus venosus congenital heart defect ,Titin ,Physiology ,Diastole ,Cardiomyopathy ,Physiology (medical) ,Internal medicine ,Medicine ,ANKRD1, Sinus venosus congenital heart defect, Diastolic dysfunction, Cardiomyocyte structure and contractility, Titin ,Sinus venosus ,Ejection fraction ,Heart development ,Embryonic heart ,business.industry ,medicine.disease ,medicine.anatomical_structure ,ANKRD1, cardiac myocytes, myocardial myofibrils, pulmonary venous return, heart failure, embryonic heart tube development, fetal heart, ANKRD1 transgenic mice,hemodynamic ,Heart failure ,Cardiomyocyte structure and contractility ,Cardiology ,Diastolic dysfunction ,Cardiology and Cardiovascular Medicine ,business - Abstract
AimsIncreased Ankyrin Repeat Domain 1 (ANKRD1) levels linked to gain of function mutations have been associated to total anomalous pulmonary venous return and adult cardiomyopathy occurrence in humans. The link between increased ANKRD1 level and cardiac structural and functional disease is not understood. To get insight into this problem, we have generated a gain of function ANKRD1 mouse model by overexpressing ANKRD1 in the myocardium.Methods and resultsAnkrd1 is expressed non-homogeneously in the embryonic myocardium, with a dynamic nucleo-sarcomeric localization in developing cardiomyocytes. ANKRD1 transgenic mice present sinus venosus defect, which originates during development by impaired remodelling of early embryonic heart. Adult transgenic hearts develop diastolic dysfunction with preserved ejection fraction, which progressively evolves into heart failure, as shown histologically and haemodynamically. Transgenic cardiomyocyte structure, sarcomeric assembly, and stability are progressively impaired from embryonic to adult life. Postnatal transgenic myofibrils also present characteristic functional alterations: impaired compliance at neonatal stage and impaired lusitropism in adult hearts. Altogether, our combined analyses suggest that impaired embryonic remodelling and adult heart dysfunction in ANKRD1 transgenic mice present a common ground of initial cardiomyocyte defects, which are exacerbated postnatally. Molecular analysis showed transient activation of GATA4-Nkx2.5 transcription in early transgenic embryos and subsequent dynamic transcriptional modulation within titin gene.ConclusionsANKRD1 is a fine mediator of cardiomyocyte response to haemodynamic load in the developing and adult heart. Increased ANKRD1 levels are sufficient to initiate an altered cellular phenotype, which is progressively exacerbated into a pathological organ response by the high ventricular workload during postnatal life. Our study defines for the first time a unifying picture for ANKRD1 role in heart development and disease and provides the first mechanistic link between ANKRD1 overexpression and cardiac disease onset.
- Published
- 2020
3. Advanced Morpho-Functional Analysis on Ventricular and Atrial Tissue Reveals Cross-Bridge Kinetics Alterations and Sarcomere Energetic Impairment in Hcm Patients
- Author
-
Leonardo Sacconi, Corrado Poggesi, Francesco Giardini, Irene Costantini, Claudia Crocini, Manuel J. Pioner, Nicoletta Piroddi, Beatrice Scellini, Erica Lazzeri, Giulia Vitale, Giacomo Mazzamuto, Francesco S. Pavone, Chiara Tesi, and Cecilia Ferrantini
- Subjects
0303 health sciences ,medicine.medical_specialty ,biology ,business.industry ,Biophysics ,Morpho ,Atrial tissue ,biology.organism_classification ,Sarcomere ,03 medical and health sciences ,0302 clinical medicine ,E258K cardiac myosin-binding protein-C, HCM, human cardiac muscle ,Cross bridge kinetics ,Internal medicine ,medicine ,Cardiology ,cardiovascular system ,cardiovascular diseases ,business ,030217 neurology & neurosurgery ,030304 developmental biology - Published
- 2019
4. Novel insights on the relationship between T-tubular defects and contractile dysfunction in a mouse model of hypertrophic cardiomyopathy
- Author
-
Long-Sheng Song, Francesco S. Pavone, Luca Mazzoni, Chiara Tesi, Josè Manuel Pioner, Claudia Crocini, Leonardo Sacconi, Jil C. Tardiff, Elisabetta Cerbai, Beatrice Scellini, Ping Yan, Leslie M. Loew, Erica Lazzeri, Cecilia Ferrantini, Francesco Vanzi, Raffaele Coppini, Ang Guo, Corrado Poggesi, and Marina Scardigli
- Subjects
AP −, Failing T-tubules ,0301 basic medicine ,Myofilament ,Action Potentials ,Gene Expression ,030204 cardiovascular system & hematology ,Imaging ,T-tubule ,Mice ,Sarcolemma ,0302 clinical medicine ,Myofibrils ,TATS, Transverse-axial tubular system ,Myocyte ,Myocytes, Cardiac ,TTP, Time-to-peak ,EXCITATION-CONTRACTION COUPLING ,IMAGING, NON-LINEAR MICROSCOPY, HYPERTROPHIC CARDIOMYOPATHY, T-TUBULE ,Excitation Contraction Coupling ,AP, Action potential ,HCM, Hypertrophic cardiomyopathy ,Mice, Knockout ,Microscopy, Confocal ,Chemistry ,Optical Imaging ,Hypertrophic cardiomyopathy ,Actin Cytoskeleton ,medicine.anatomical_structure ,AP +, Electrically coupled T-tubules ,Non-linear microscopy ,T-tubules ,Original Article ,Cardiology and Cardiovascular Medicine ,RAMP, Random access multi-photon ,medicine.medical_specialty ,HF, Heart failure ,Excitation–contraction coupling ,03 medical and health sciences ,Troponin T ,AOD, Acousto-optic deflector ,Internal medicine ,medicine ,Animals ,Humans ,Calcium Signaling ,Molecular Biology ,CaT50, Time of 50% Ca2 + decay ,Ion Transport ,TT, T-tubule ,S/N, Signal-to-noise ratio ,Cardiomyopathy, Hypertrophic ,Actin cytoskeleton ,medicine.disease ,Myocardial Contraction ,Excitation-contraction coupling ,Disease Models, Animal ,030104 developmental biology ,Endocrinology ,SS, Surface sarcolemma ,Mutation ,Calcium ,cTnT, Cardiac troponin T ,E–C, Excitation–contraction ,Myofibril ,VSD, Voltage sensitive dye ,Homeostasis - Abstract
Abnormalities of cardiomyocyte Ca2 + homeostasis and excitation–contraction (E–C) coupling are early events in the pathogenesis of hypertrophic cardiomyopathy (HCM) and concomitant determinants of the diastolic dysfunction and arrhythmias typical of the disease. T-tubule remodelling has been reported to occur in HCM but little is known about its role in the E–C coupling alterations of HCM. Here, the role of T-tubule remodelling in the electro-mechanical dysfunction associated to HCM is investigated in the Δ160E cTnT mouse model that expresses a clinically-relevant HCM mutation. Contractile function of intact ventricular trabeculae is assessed in Δ160E mice and wild-type siblings. As compared with wild-type, Δ160E trabeculae show prolonged kinetics of force development and relaxation, blunted force-frequency response with reduced active tension at high stimulation frequency, and increased occurrence of spontaneous contractions. Consistently, prolonged Ca2 + transient in terms of rise and duration are also observed in Δ160E trabeculae and isolated cardiomyocytes. Confocal imaging in cells isolated from Δ160E mice reveals significant, though modest, remodelling of T-tubular architecture. A two-photon random access microscope is employed to dissect the spatio-temporal relationship between T-tubular electrical activity and local Ca2 + release in isolated cardiomyocytes. In Δ160E cardiomyocytes, a significant number of T-tubules (> 20%) fails to propagate action potentials, with consequent delay of local Ca2 + release. At variance with wild-type, we also observe significantly increased variability of local Ca2 + transient rise as well as higher Ca2 +-spark frequency. Although T-tubule structural remodelling in Δ160E myocytes is modest, T-tubule functional defects determine non-homogeneous Ca2 + release and delayed myofilament activation that significantly contribute to mechanical dysfunction., Highlights • Contraction and Ca2 + transient kinetics are impaired in myocardial preparations from mice carrying the cardiac troponin T ∆ 160E mutation. • T-tubules architecture is mildly altered in ∆160E cardiomyocytes. • 20% of T-tubules fail to propagate action potential and produce delay of local Ca2 + rise. • Higher spatio-temporal variability of local Ca2 + rise and increased Ca2 + sparks frequency are found in ∆160E cardiomyocytes.
- Published
- 2016
5. R4496C RyR2 mutation impairs atrial and ventricular contractility
- Author
-
Chiara Tesi, Luca Mazzoni, Cecilia Ferrantini, Josè Manuel Pioner, Claudia Ferrara, Raffaele Coppini, Elisabetta Cerbai, Silvia G. Priori, Beatrice Scellini, and Corrado Poggesi
- Subjects
0301 basic medicine ,Inotrope ,medicine.medical_specialty ,Calcium Channels, L-Type ,Physiology ,Heart Ventricles ,Mice, Transgenic ,030204 cardiovascular system & hematology ,Catecholaminergic polymorphic ventricular tachycardia ,Ryanodine receptor 2 ,Contractility ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,Animals ,Myocyte ,Myocytes, Cardiac ,cardiovascular diseases ,Calcium Signaling ,Heart Atria ,Research Articles ,Voltage-dependent calcium channel ,Chemistry ,Ryanodine receptor ,Isoproterenol ,Arrhythmias, Cardiac ,Ryanodine Receptor Calcium Release Channel ,medicine.disease ,Mice, Inbred C57BL ,Sarcoplasmic Reticulum ,030104 developmental biology ,Endocrinology ,Mutation ,Tachycardia, Ventricular ,cardiovascular system ,Cardiology ,Calcium ,medicine.symptom ,Muscle Contraction ,Muscle contraction - Abstract
A ryanodine receptor 2 mutation associated with catecholaminergic polymorphic ventricular tachycardia renders cardiomyocytes incapable of mediating a positive inotropic response., Ryanodine receptor (RyR2) is the major Ca2+ channel of the cardiac sarcoplasmic reticulum (SR) and plays a crucial role in the generation of myocardial force. Changes in RyR2 gating properties and resulting increases in its open probability (Po) are associated with Ca2+ leakage from the SR and arrhythmias; however, the effects of RyR2 dysfunction on myocardial contractility are unknown. Here, we investigated the possibility that a RyR2 mutation associated with catecholaminergic polymorphic ventricular tachycardia, R4496C, affects the contractile function of atrial and ventricular myocardium. We measured isometric twitch tension in left ventricular and atrial trabeculae from wild-type mice and heterozygous transgenic mice carrying the R4496C RyR2 mutation and found that twitch force was comparable under baseline conditions (30°C, 2 mM [Ca2+]o, 1 Hz). However, the positive inotropic responses to high stimulation frequency, 0.1 µM isoproterenol, and 5 mM [Ca2+]o were decreased in R4496C trabeculae, as was post-rest potentiation. We investigated the mechanisms underlying inotropic insufficiency in R4496C muscles in single ventricular myocytes. Under baseline conditions, the amplitude of the Ca2+ transient was normal, despite the reduced SR Ca2+ content. Under inotropic challenge, however, R4496C myocytes were unable to boost the amplitude of Ca2+ transients because they are incapable of properly increasing the amount of Ca2+ stored in the SR because of a larger SR Ca2+ leakage. Recovery of force in response to premature stimuli was faster in R4496C myocardium, despite the unchanged rates of recovery of L-type Ca2+ channel current (ICa-L) and SR Ca2+ content in single myocytes. A faster recovery from inactivation of the mutant R4496C channels could explain this behavior. In conclusion, changes in RyR2 channel gating associated with the R4496C mutation could be directly responsible for the alterations in both ventricular and atrial contractility. The increased RyR2 Po and fractional Ca2+ release from the SR induced by the R4496C mutation preserves baseline contractility despite a slight decrease in SR Ca2+ content, but cannot compensate for the inability to increase SR Ca2+ content during inotropic challenge.
- Published
- 2015
6. The Missense E258K-MyBP-C Mutation Increases the Energy Cost of Tension Generation in Both Ventricular and Atrial Tissue from HCM Patients
- Author
-
Corrado Poggesi, Josè Manuel Pioner, Iacopo Olivotto, Nicoletta Piroddi, Beatrice Scellini, Francesca Gentile, Giulia Vitale, Cecilia Ferrantini, and Chiara Tesi
- Subjects
medicine.medical_specialty ,Tension (physics) ,business.industry ,Internal medicine ,Mutation (genetic algorithm) ,Biophysics ,Cardiology ,medicine ,Energy cost ,Missense mutation ,Atrial tissue ,Hypertrophic CardioMyopathy (HCM), MYBPC3 mutation, cardiac tissue, human cardiac myofibrils,sarcomere energetic ,business - Published
- 2018
7. Pathogenesis of hypertrophic cardiomyopathy is mutation rather than disease specific: A comparison of the cardiac troponin T E163R and R92Q mouse models
- Author
-
Pieter P. de Tombe, Beatrice Scellini, Cecilia Ferrantini, Elisabetta Cerbai, Raffaele Coppini, Lorenzo Santini, Nicoletta Piroddi, Annunziatina Laurino, Valentina Spinelli, Leonardo Sacconi, Jil C. Tardiff, Chiara Tesi, Iacopo Olivotto, Rachel K. Moore, Josè Manuel Pioner, Francesca Gentile, Luca Mazzoni, Alessandro Mugelli, Corrado Poggesi, and Benedetta Tosi
- Subjects
0301 basic medicine ,Male ,030204 cardiovascular system & hematology ,medicine.disease_cause ,Calcium Cycling/Excitation-Contraction Coupling ,Ventricular Function, Left ,Pathogenesis ,Ventricular Dysfunction, Left ,0302 clinical medicine ,Myofibrils ,Genetically Altered and Transgenic Models ,Myocytes, Cardiac ,Excitation Contraction Coupling ,Original Research ,Mutation ,Troponin T ,Ventricular Remodeling ,Hypertrophic cardiomyopathy ,Phenotype ,Cardiology ,Christian ministry ,Hypertrophy, Left Ventricular ,Sarcomere physiology ,Cardiology and Cardiovascular Medicine ,Disease specific ,Genetic Markers ,medicine.medical_specialty ,Cardiac troponin ,Cardiomyopathy ,Mice, Transgenic ,Pathophysiology ,Sarcoplasmic Reticulum Calcium-Transporting ATPases ,03 medical and health sciences ,Internal medicine ,medicine ,Animals ,Genetic Predisposition to Disease ,Calcium Signaling ,Ventricular remodeling ,Heart Failure ,excitation‐contraction coupling ,business.industry ,Excitation-contraction coupling ,Cardiomyopathy, Hypertrophic ,medicine.disease ,Fibrosis ,Mice, Inbred C57BL ,Disease Models, Animal ,030104 developmental biology ,Calcium-Calmodulin-Dependent Protein Kinases ,Contractile function ,business - Abstract
Background In cardiomyocytes from patients with hypertrophic cardiomyopathy, mechanical dysfunction and arrhythmogenicity are caused by mutation‐driven changes in myofilament function combined with excitation‐contraction (E‐C) coupling abnormalities related to adverse remodeling. Whether myofilament or E‐C coupling alterations are more relevant in disease development is unknown. Here, we aim to investigate whether the relative roles of myofilament dysfunction and E‐C coupling remodeling in determining the hypertrophic cardiomyopathy phenotype are mutation specific. Methods and Results Two hypertrophic cardiomyopathy mouse models carrying the R92Q and the E163R TNNT2 mutations were investigated. Echocardiography showed left ventricular hypertrophy, enhanced contractility, and diastolic dysfunction in both models; however, these phenotypes were more pronounced in the R92Q mice. Both E163R and R92Q trabeculae showed prolonged twitch relaxation and increased occurrence of premature beats. In E163R ventricular myofibrils or skinned trabeculae, relaxation following Ca 2+ removal was prolonged; resting tension and resting ATPase were higher; and isometric ATPase at maximal Ca 2+ activation, the energy cost of tension generation, and myofilament Ca 2+ sensitivity were increased compared with that in wild‐type mice. No sarcomeric changes were observed in R92Q versus wild‐type mice, except for a large increase in myofilament Ca 2+ sensitivity. In R92Q myocardium, we found a blunted response to inotropic interventions, slower decay of Ca 2+ transients, reduced SERCA function, and increased Ca 2+ /calmodulin kinase II activity. Contrarily, secondary alterations of E‐C coupling and signaling were minimal in E163R myocardium. Conclusions In E163R models, mutation‐driven myofilament abnormalities directly cause myocardial dysfunction. In R92Q, diastolic dysfunction and arrhythmogenicity are mediated by profound cardiomyocyte signaling and E‐C coupling changes. Similar hypertrophic cardiomyopathy phenotypes can be generated through different pathways, implying different strategies for a precision medicine approach to treatment.
- Published
- 2017
8. HDAC6 contributes to pathological responses of heart and skeletal muscle to chronic angiotensin-II signaling
- Author
-
Corrado Poggesi, Jennifer H. Mahaffey, Maria A. Cavasin, Timothy A. McKinsey, Katherine B. Schuetze, Jessica I. Spiltoir, Mark Y. Jeong, Beatrice Scellini, Bradley S. Ferguson, Claudia Ferrara, Sarah M. Williams, Chiara Tesi, Bo Chen, Todd R. Horn, Nicoletta Piroddi, and Kimberly M. Demos-Davies
- Subjects
Male ,Cardiac function curve ,medicine.medical_specialty ,Indoles ,Time Factors ,Systole ,Physiology ,Cardiomegaly ,Biology ,Histone Deacetylase 6 ,Hydroxamic Acids ,Histone Deacetylases ,Ventricular Function, Left ,Mice ,Physiology (medical) ,Internal medicine ,medicine ,Animals ,Muscle, Skeletal ,Ventricular remodeling ,Heart Failure ,Mice, Knockout ,Pressure overload ,Ventricular Remodeling ,Angiotensin II ,Myocardium ,Skeletal muscle ,Stroke Volume ,medicine.disease ,Fibrosis ,Muscle atrophy ,Histone Deacetylase Inhibitors ,Disease Models, Animal ,Muscular Atrophy ,medicine.anatomical_structure ,Endocrinology ,Heart failure ,cardiovascular system ,Rapid Reports ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,Myofibril ,Signal Transduction - Abstract
Little is known about the function of the cytoplasmic histone deacetylase HDAC6 in striated muscle. Here, we addressed the role of HDAC6 in cardiac and skeletal muscle remodeling induced by the peptide hormone angiotensin II (ANG II), which plays a central role in blood pressure control, heart failure, and associated skeletal muscle wasting. Comparable with wild-type (WT) mice, HDAC6 null mice developed cardiac hypertrophy and fibrosis in response to ANG II. However, whereas WT mice developed systolic dysfunction upon treatment with ANG II, cardiac function was maintained in HDAC6 null mice treated with ANG II for up to 8 wk. The cardioprotective effect of HDAC6 deletion was mimicked in WT mice treated with the small molecule HDAC6 inhibitor tubastatin A. HDAC6 null mice also exhibited improved left ventricular function in the setting of pressure overload mediated by transverse aortic constriction. HDAC6 inhibition appeared to preserve systolic function, in part, by enhancing cooperativity of myofibrillar force generation. Finally, we show that HDAC6 null mice are resistant to skeletal muscle wasting mediated by chronic ANG-II signaling. These findings define novel roles for HDAC6 in striated muscle and suggest potential for HDAC6-selective inhibitors for the treatment of cardiac dysfunction and muscle wasting in patients with heart failure.
- Published
- 2014
9. Faster cross-bridge detachment and increased tension cost in human hypertrophic cardiomyopathy with the R403QMYH7mutation
- Author
-
Claudia Ferrara, Beatrice Scellini, Corrado Poggesi, Theresia Kraft, Judith Montag, E. Rosalie Witjas-Paalberends, Nicoletta Piroddi, Michelle Michels, Ger J.M. Stienen, Chiara Tesi, Carolyn Y. Ho, and Jolanda van der Velden
- Subjects
Genetics ,medicine.medical_specialty ,Physiology ,Chemistry ,Hypertrophic cardiomyopathy ,Cardiac muscle ,macromolecular substances ,medicine.disease ,Sarcomere ,medicine.anatomical_structure ,Endocrinology ,Muscle relaxation ,Internal medicine ,Myosin ,medicine ,Missense mutation ,MYH7 ,Myofibril - Abstract
The first mutation associated with hypertrophic cardiomyopathy (HCM) is the R403Q mutation in the gene encoding β-myosin heavy chain (β-MyHC). R403Q locates in the globular head of myosin (S1), responsible for interaction with actin, and thus motor function of myosin. Increased cross-bridge relaxation kinetics caused by the R403Q mutation might underlie increased energetic cost of tension generation; however, direct evidence is absent. Here we studied to what extent cross-bridge kinetics and energetics are related in single cardiac myofibrils and multicellular cardiac muscle strips of three HCM patients with the R403Q mutation and nine sarcomere mutation-negative HCM patients (HCMsmn). Expression of R403Q was on average 41 ± 4% of total MYH7 mRNA. Cross-bridge slow relaxation kinetics in single R403Q myofibrils was significantly higher (P < 0.0001) than in HCMsmn myofibrils (0.47 ± 0.02 and 0.30 ± 0.02 s-1, respectively). Moreover, compared to HCMsmn, tension cost was significantly higher in the muscle strips of the three R403Q patients (2.93 ± 0.25 and 1.78 ± 0.10 μmol l-1 s-1 kN-1 m-2, respectively) which showed a positive linear correlation with relaxation kinetics in the corresponding myofibril preparations. This correlation suggests that faster cross-bridge relaxation kinetics results in an increase in energetic cost of tension generation in human HCM with the R403Q mutation compared to HCMsmn. Therefore, increased tension cost might contribute to HCM disease in patients carrying the R403Q mutation.
- Published
- 2014
10. The homozygous K280N troponin T mutation alters cross-bridge kinetics and energetics in human HCM
- Author
-
Cecilia Ferrantini, Corrado Poggesi, Vasco Sequiera, Claudia Ferrara, Andrew E. Messer, Lucie Carrier, Paul J.M. Wijnker, Annibale Biggeri, Dennis Dooijes, Charles Redwood, Chiara Tesi, Cristobal G. dos Remedios, Man Ching Leung, Steven B. Marston, Saskia Schlossarek, Douglas G. Ward, Giulia Vitale, E. Rosalie Witjas-Paalberends, Beatrice Scellini, Nicoletta Piroddi, Jolanda van der Velden, Physiology, and ACS - Heart failure & arrhythmias
- Subjects
0301 basic medicine ,Male ,Myofilament ,HUMAN HYPERTROPHIC CARDIOMYOPATHY ,TNNT2 ,Physiology ,Muscle Relaxation ,BETA-MYOSIN ,MECHANICAL PERFORMANCE ,Sarcomere ,0302 clinical medicine ,Myofibrils ,HUMAN CARDIAC TROPONIN ,PHOSPHORYLATION ,Research Articles ,biology ,Troponin T ,Chemistry ,Hypertrophic cardiomyopathy ,Cardiac muscle ,musculoskeletal system ,Sarcomere, Cardiac Muscle, Troponin, Hypertrophic Cardiomyopathy, Cross Bridge ,Troponin ,3. Good health ,medicine.anatomical_structure ,cardiovascular system ,Life Sciences & Biomedicine ,Research Article ,Adult ,Sarcomeres ,medicine.medical_specialty ,Hypertrophic Cardiomyopathy ,RELAXATION ,macromolecular substances ,News ,LENGTH-DEPENDENT ACTIVATION ,Research News ,03 medical and health sciences ,Internal medicine ,Cardiac Muscle ,medicine ,Journal Article ,Humans ,cardiovascular diseases ,PROTEIN-KINASE-A ,Science & Technology ,Cardiomyopathy, Hypertrophic ,0606 Physiology ,medicine.disease ,Kinetics ,TENSION GENERATION ,030104 developmental biology ,Endocrinology ,Cross Bridge ,MUTANT ,1116 Medical Physiology ,Mutation ,biology.protein ,Calcium ,Myofibril ,030217 neurology & neurosurgery - Abstract
Hypertrophic cardiomyopathy (HCM) is caused by mutations in sarcomeric proteins, but the pathogenic mechanism is unclear. Piroddi et al. find impairment of cross-bridge kinetics and energetics in human sarcomeres with a TNNT2 mutation, suggesting that HCM involves inefficient ATP utilization., Hypertrophic cardiomyopathy (HCM) is a genetic form of left ventricular hypertrophy, primarily caused by mutations in sarcomere proteins. The cardiac remodeling that occurs as the disease develops can mask the pathogenic impact of the mutation. Here, to discriminate between mutation-induced and disease-related changes in myofilament function, we investigate the pathogenic mechanisms underlying HCM in a patient carrying a homozygous mutation (K280N) in the cardiac troponin T gene (TNNT2), which results in 100% mutant cardiac troponin T. We examine sarcomere mechanics and energetics in K280N-isolated myofibrils and demembranated muscle strips, before and after replacement of the endogenous troponin. We also compare these data to those of control preparations from donor hearts, aortic stenosis patients (LVHao), and HCM patients negative for sarcomeric protein mutations (HCMsmn). The rate constant of tension generation following maximal Ca2+ activation (kACT) and the rate constant of isometric relaxation (slow kREL) are markedly faster in K280N myofibrils than in all control groups. Simultaneous measurements of maximal isometric ATPase activity and Ca2+-activated tension in demembranated muscle strips also demonstrate that the energy cost of tension generation is higher in the K280N than in all controls. Replacement of mutant protein by exchange with wild-type troponin in the K280N preparations reduces kACT, slow kREL, and tension cost close to control values. In donor myofibrils and HCMsmn demembranated strips, replacement of endogenous troponin with troponin containing the K280N mutant increases kACT, slow kREL, and tension cost. The K280N TNNT2 mutation directly alters the apparent cross-bridge kinetics and impairs sarcomere energetics. This result supports the hypothesis that inefficient ATP utilization by myofilaments plays a central role in the pathogenesis of the disease.
- Published
- 2019
11. Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy
- Author
-
Marjon van Slegtenhorst, Beatrice Scellini, Kelly Stam, Vasco Sequeira Oliviera, Mark R. Hazebroek, Folkert J. ten Cate, Chiara Tesi, Claudia Ferrara, Ger J.M. Stienen, Stephane Heymans, Michelle Michels, Cris dos Remedios, E. Rosalie Witjas-Paalberends, Nicoletta Piroddi, Sabine J. van Dijk, Corrado Poggesi, Hans W.M. Niessen, Jolanda van der Velden, Cardiology, Physiology, Neurology, Pathology, ICaR - Heartfailure and pulmonary arterial hypertension, Promovendi CD, Cardiologie, RS: CARIM School for Cardiovascular Diseases, and Physics of Living Systems
- Subjects
Adult ,Male ,Sarcomeres ,congenital, hereditary, and neonatal diseases and abnormalities ,medicine.medical_specialty ,Myofilament ,Physiology ,TNNT2 ,Cardiomyopathy ,TPM1 ,Cell Enlargement ,030204 cardiovascular system & hematology ,Gene mutation ,Contractility ,Sarcomere ,Muscle hypertrophy ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Myofibrils ,SDG 3 - Good Health and Well-being ,Physiology (medical) ,Internal medicine ,Cardiomyopathy, Hypertrophic, Familial ,medicine ,Humans ,Myocytes, Cardiac ,cardiovascular diseases ,Aged ,030304 developmental biology ,0303 health sciences ,Myosin Heavy Chains ,Chemistry ,Hypertrophy ,Middle Aged ,Fibrosis ,Myocardial Contraction ,Mutation ,cardiovascular system ,Cardiology ,Calcium ,Female ,MYH7 ,Cardiology and Cardiovascular Medicine ,Myofibril ,Sarcomere proteins ,Cardiac Myosins - Abstract
Aims Familial hypertrophic cardiomyopathy (HCM), frequently caused by sarcomeric gene mutations, is characterized by cellular dysfunction and asymmetric left-ventricular (LV) hypertrophy. We studied whether cellular dysfunction is due to an intrinsic sarcomere defect or cardiomyocyte remodelling. Methods and results Cardiac samples from 43 sarcomere mutation-positive patients (HCMmut: mutations in thick ( MYBPC3 , MYH7 ) and thin ( TPM1 , TNNI3 , TNNT2 ) myofilament genes) were compared with 14 sarcomere mutation-negative patients (HCMsmn), eight patients with secondary LV hypertrophy due to aortic stenosis (LVHao) and 13 donors. Force measurements in single membrane-permeabilized cardiomyocytes revealed significantly lower maximal force generating capacity (Fmax) in HCMmut (21 ± 1 kN/m2) and HCMsmn (26 ± 3 kN/m2) compared with donor (36 ± 2 kN/m2). Cardiomyocyte remodelling was more severe in HCMmut compared with HCMsmn based on significantly lower myofibril density (49 ± 2 vs. 63 ± 5%) and significantly higher cardiomyocyte area (915 ± 15 vs. 612 ± 11 μm2). Low Fmax in MYBPC3 mut, TNNI3 mut, HCMsmn, and LVHao was normalized to donor values after correction for myofibril density. However, Fmax was significantly lower in MYH7 mut, TPM1 mut, and TNNT2 mut even after correction for myofibril density. In accordance, measurements in single myofibrils showed very low Fmax in MYH7 mut, TPM1 mut, and TNNT2 mut compared with donor (respectively, 73 ± 3, 70 ± 7, 83 ± 6, and 113 ± 5 kN/m2). In addition, force was lower in MYH7 mut cardiomyocytes compared with MYBPC3 mut, HCMsmn, and donor at submaximal [Ca2+]. Conclusion Low cardiomyocyte Fmax in HCM patients is largely explained by hypertrophy and reduced myofibril density. MYH7 mutations reduce force generating capacity of sarcomeres at maximal and submaximal [Ca2+]. These hypocontractile sarcomeres may represent the primary abnormality in patients with MYH7 mutations.
- Published
- 2013
12. Myopalladin is upregulated in dilated cardiomyopathies patients and myopalladin knockout mice develop cardiac dilation and dysfunction following pressure overload
- Author
-
Roman S. Polishchuk, P. Carullo, R. Crispino, Chiara Tesi, D.L. Yamamoto, M.L. Bang, M.C. Filomena, Jianlin Zhang, Beatrice Scellini, R. Knöll, Corrado Poggesi, and Nicoletta Piroddi
- Subjects
Pressure overload ,Myopalladin, sarcomeric protein, cardiomyopathy ,medicine.medical_specialty ,Downregulation and upregulation ,business.industry ,Internal medicine ,Knockout mouse ,medicine ,Cardiology ,Dilation (morphology) ,Cardiology and Cardiovascular Medicine ,business ,Molecular Biology - Published
- 2018
13. The familial hypertrophic cardiomyopathy-associated myosin mutation R403Q accelerates tension generation and relaxation of human cardiac myofibrils
- Author
-
Magdi H Yacoub, Corrado Poggesi, Iacopo Olivotto, Giulia d' Amati, Franco Cecchi, Beatrice Scellini, Alexandra Belus, Nicoletta Piroddi, Francesca Girolami, and Chiara Tesi
- Subjects
Calcium metabolism ,medicine.medical_specialty ,Familial Hypertrophic Cardiomyopathy ,Contraction (grammar) ,Physiology ,Cardiomyopathy ,Energetic cost ,Biology ,medicine.disease ,Mutant protein ,Internal medicine ,Myosin ,medicine ,Cardiology ,Myofibril - Abstract
The R403Q mutation in β-myosin heavy chain was the first mutation to be identified as responsible for familial hypertrophic cardiomyopathy (FHC). In spite of extensive work on the functional sequelae of this mutation, the mechanism by which the mutant protein causes the disease has not been definitely identified. Here we directly compare contraction and relaxation mechanics of single myofibrils from left ventricular samples of one patient carrying the R403Q mutation to those from a healthy control heart. Tension generation and relaxation following sudden increase and decrease in [Ca2+] were much faster in the R403Q myofibrils with relaxation rates being the most affected parameters. The results show that the R403Q mutation leads to an apparent gain of protein function but a greater energetic cost of tension generation. Increased energy cost of tension generation may be central to the FHC disease process, help explain some unresolved clinical observations, and carry significant therapeutic implications.
- Published
- 2008
14. Myocardial Dysfunction in Hypertrophic Cardiomyopathy: Primary Effects of Sarcomeric Mutations Versus Secondary EC-Coupling Remodelling
- Author
-
Corrado Poggesi, Manuel J. Pioner, Francesca Gentile, Benedetta Tosi, Chiara Tesi, Raffaele Coppini, Cecilia Ferrantini, Beatrice Scellini, Elisabetta Cerbai, Luca Mazzoni, Jil C. Tardiff, and Nicoletta Piroddi
- Subjects
medicine.medical_specialty ,Myofilament ,SERCA ,Cardiac, HCM, myocardial dysfunction, Troponin T, Calcium sensitivity, sarcomere function ,Chemistry ,Cardiac muscle ,Diastole ,Hypertrophic cardiomyopathy ,Biophysics ,Anatomy ,medicine.disease ,Sarcomere ,Contractility ,medicine.anatomical_structure ,Endocrinology ,Internal medicine ,cardiovascular system ,medicine ,Myofibril - Abstract
In cardiac muscle from HCM patients primary changes in myofilament function, related to the presence of disease-causing mutations in sarcomeric proteins, are always associated with secondary abnormalities due to adverse remodeling of cardiomyocyte EC-coupling(Coppini et al,Circulation 2013). The latter are likely major contributors of the mechanical dysfunction and arrhythmogeneity of HCM human hearts. Here we characterize the changes in sarcomere function and EC-coupling that occur in two HCM mouse models carrying different mutations in cTnT (R92Q and E163R). Echocardiography showed LV hypertrophy, enhanced contractility, diastolic dysfunction and enlarged left atria in both HCM models; the phenotype was more pronounced in the R92Q mice. In E163R ventricular myofibrils, in spite of a significant increase in the rate of the initial isometric slow phase of relaxation, overall relaxation from maximal activation was impaired and prolonged vs WT and R92Q myofibrils that exhibited similar relaxation kinetics. Resting tension was higher in the E163Q compared to WT and R92Q myofibrils. Isometric ATPase both at rest and at maximal Ca2+-activation and the energy cost of tension generation were increased in E163R vs WT and R92Q skinned trabeculae. Myofilament Ca2+-sensitivity was increased in both mutant lines compared to WT; the change was larger in the R92Q preparations. R92Q intact cardiomyocytes and trabeculae compared to WT and E163R preparations showed blunted response to inotropic interventions, reduced amplitude and slower decay of Ca2+-transients with reduced SERCA function. Twitch kinetics were prolonged in both HCM mouse models, despite Ca2+-transient kinetics was faster and SERCA function unchanged in the E163R mice. Intact preparations of both HCM mouse models showed increased probability of arrhythmogenic behavior that increased in response to isoproterenol. The results suggest that similar HCM phenotypes can be generated through different pathogenic pathways. Grant Telethon-GGP13162.
- Published
- 2015
15. Tension generation and relaxation in single myofibrils from human atrial and ventricular myocardium
- Author
-
Nicoletta Piroddi, Gabriele Giunti, Beatrice Scellini, Corrado Poggesi, Alexandra Belus, Alessandro Mugelli, Chiara Tesi, and Elisabetta Cerbai
- Subjects
Adult ,Male ,Sarcomeres ,medicine.medical_specialty ,animal structures ,Contraction (grammar) ,Physiology ,Heart Ventricles ,Clinical Biochemistry ,macromolecular substances ,Sarcomere ,Phosphates ,Myofibrils ,Physical Stimulation ,Physiology (medical) ,Internal medicine ,Myosin ,Reaction Time ,medicine ,Humans ,Heart Atria ,Actin ,Aged ,Dose-Response Relationship, Drug ,biology ,Chemistry ,Myocardium ,Heart ,Middle Aged ,musculoskeletal system ,Myocardial Contraction ,Troponin ,Solutions ,Kinetics ,Bepridil ,biology.protein ,Cardiology ,Biophysics ,Feasibility Studies ,Calcium ,Female ,Titin ,Myofibril ,medicine.drug - Abstract
Fast solution switching techniques in single myofibrils offer the opportunity to dissect and directly examine the sarcomeric mechanisms responsible for force generation and relaxation. The feasibility of this approach is tested here in human cardiac myofibrils isolated from small samples of atrial and ventricular tissue. At sarcomere lengths between 2.0 and 2.3 mum, resting tensions were significantly higher in ventricular than in atrial myofibrils. The rate constant of active tension generation after maximal Ca(2+) activation (k (ACT)) was markedly faster in atrial than in ventricular myofibrils. In both myofibril types k (ACT) was the same as the rate of tension redevelopment after mechanical perturbations and decreased significantly by decreasing [Ca(2+)] in the activating solution. Upon sudden Ca(2+) removal, active tension fully relaxed. Relaxation kinetics were (1) much faster in atrial than in ventricular myofibrils, (2) unaffected by bepridil, a drug that increases the affinity of troponin for Ca(2+), and (3) strongly accelerated by small increases in inorganic phosphate concentration. The results indicate that myofibril tension activation and relaxation rates reflect apparent cross-bridge kinetics and their Ca(2+) regulation rather than the rates at which thin filaments are switched on or off by Ca(2+) binding or removal. Myofibrils from human hearts retain intact mechanisms for contraction regulation and tension generation and represent a viable experimental model to investigate function and dysfunction of human cardiac sarcomeres.
- Published
- 2006
16. Mechanical Remodeling of Atrial Myocardium in HCM Mouse Models Carrying CTNT Mutations
- Author
-
Chiara Tesi, Cecilia Ferrantini, Corrado Poggesi, Beatrice Scellini, Jil C. Tardiff, Raffaele Coppini, Francesca Gentile, and Josè Manuel Pioner
- Subjects
Inotrope ,Fibrillation ,medicine.medical_specialty ,business.industry ,Biophysics ,Hypertrophic cardiomyopathy ,Diastole ,Anatomy ,medicine.disease ,Sarcomere ,Troponin complex ,Internal medicine ,cardiovascular system ,Extracellular ,Cardiology ,medicine ,Atrial myocardium ,cardiovascular diseases ,medicine.symptom ,business - Abstract
In hypertrophic cardiomyopathy (HCM) atrial dilatation (AD) and fibrillation (AF) are very common and associated with worse outcome. The cellular and molecular basis of atrial remodeling in HCM remain undefined. We previously characterized (Coppini et al. ABS Biophysical Journal 2015) the changes in sarcomere function and E-C coupling that occur in ventricular myocardium of two HCM mouse models carrying different mutations in cTnT (R92Q and E163R). Both models exhibited diastolic dysfunction that was, however, related to different mechanisms i.e. E-C coupling abnormalities in R92Q and sarcomere changes in E163R. Here we employ these mouse models to study whether atrial remodeling is a consequence of diastolic dysfunction or is also influenced by the specific underlying mutation.Echocardiographic measurements of left atrial (LA) dimensions showed that LA area was severely increased in R92Q hearts while it was only mildly increased in E163R (in mm2 : 6.73±0.5 in R92Q, 4.82±0.16 in E163R vs 3.97±0.26 in WT). Left atrial trabeculae were dissected and mounted isometrically to record twitch tension. We studied the steady-state force-frequency relationship and the response to positive inotropic stimuli such as Isoproterenol 10-7 mM (ISO) and 8 mM extracellular [Ca2+]. Compared to WT, R92Q atrial trabeculae showed: (i) slower kinetics of both force development and relaxation (e.g. at 1 Hz, 50% relaxation was prolonged by 35%), (ii) impaired twitch amplitude at high pacing rates (50% reduction), (iii) depressed rested-state contractions and (iv) blunted increase of twitch tension in ISO and high [Ca2+]. None of these changes were observed in intact E163R atrial trabeculae. These findings suggest that atrial remodeling in R92Q is more pronounced compared to E163R, and related to E-C coupling alterations. Supported by the Italian Ministry of Health (WFR GR-2011-02350583).
- Published
- 2016
17. Atrial Remodeling in Hypertrophic Cardiomyopathy
- Author
-
Josè Manuel Pioner, Cristina Morelli, Corrado Poggesi, Francesca Gentile, Chiara Tesi, Elisabetta Cerbai, Jil C. Tardiff, Cecilia Ferrantini, Iacopo Olivotto, Nicoletta Piroddi, Raffaele Coppini, and Beatrice Scellini
- Subjects
medicine.medical_specialty ,Myofilament ,business.industry ,Biophysics ,Diastole ,Hypertrophic cardiomyopathy ,Isometric exercise ,Anatomy ,medicine.disease ,Sarcomere ,Troponin complex ,Internal medicine ,cardiovascular system ,medicine ,Cardiology ,cardiovascular diseases ,medicine.symptom ,Myofibril ,Myopathy ,business ,Hypertrophic Cardiomyopathy, HCM mutations, sarcomere function, diastolic dysfunction, atrial remodelling - Abstract
Changes in myofilament function related to HCM-associated mutations contribute to the diastolic dysfunction observed in the in vivo patient heart and in intact ventricular preparations from patient samples. HCM mutations that are ubiquitously expressed in the heart (e.g. cMyBP-C or cTnT) could also affect atrial function. Here we investigate whether HCM-associated atrial myopathy is a consequence of mutation-driven sarcomere dysfunction or results from atrial remodeling due to the diastolic dysfunction and increased LV filling pressures. In one HCM patient carrying the Lys814del cMyB-C mutation, changes in sarcomere function (increased myofilament Ca2+ sensitivity and increased cross bridges detachment rate under isometric conditions) were similar in atrial and ventricular myofibrils compared to donor preparations. However, isometric twitch mechanics and kinetics of intact trabeculae from the right atrium of 4 cMyB-C-mutant patients were unaffected as compared to trabeculae from non-HCM patients (N=8), or mutation negative HCM patients (N=3), or HCM patients carrying mutations in beta-myosin (N=2). We extended the study to HCM mouse models carrying mutations in cTnT. In the E163R mouse, atrial and ventricular sarcomere kinetics and energetics were similarly altered compared to WT mice. Isometric ATPase, both at rest and at maximal Ca2+-activation and the energy cost of tension generation were increased in both atrial and ventricular preparations of E163R vs WT. However, isometric twitch kinetics were prolonged in intact ventricular trabeculae of E163R mice vs WT while they were unaffected in atrial trabeculae. In the R92Q mouse model, that is associated with a much more severe degree of LV diastolic dysfunction and left atrial dilatation compared to the E163R, left atrial trabeculae showed prolonged twitch contractions, increased spontaneous activity and a number of E-C coupling alterations that resemble those observed in ventricular preparations. HCM-mutations in cMyBP-C and cTnT induce similar alterations in both atrial and ventricular sarcomeres. However, likely due to the different working conditions of the two chambers, sarcomere dysfunction can significantly alter the mechanics and kinetics of the intact myocardium only in the ventricles. Atrial muscle dysfunction in HCM is induced by remodeling processes that depend on the increased filling pressures.
- Published
- 2017
18. The HCM-Associated Cardiac Troponin T Mutation K280N Increases the Energetic Cost of Tension Generation in Human Cardiac Myofibrils
- Author
-
Nicoletta Piroddi, Corrado Poggesi, Lucie Carrier, Steve Marston, Cristobal G. dos Remedios, Saskia Schlossarek, Claudia Ferrara, E. Rosalie Witjas-Paalberends, Judy Leung, Beatrice Scellini, Vasco Sequiera, Charles Redwood, Jolanda van der Velden, and Chiara Tesi
- Subjects
0303 health sciences ,medicine.medical_specialty ,TNNT2 ,Chemistry ,Biophysics ,Isometric exercise ,Anatomy ,Sarcomere ,Transplantation ,03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,Troponin complex ,Mutant protein ,Internal medicine ,medicine ,media_common.cataloged_instance ,European union ,Myofibril ,030217 neurology & neurosurgery ,030304 developmental biology ,media_common - Abstract
A novel homozygous mutation in the TNNT2 gene encoding cardiac troponin T (cTnT K280N) was identified in one HCM patient undergoing cardiac transplantation. mRNA and Mass Spectrometry analyses revealed expression of the mutant alleles without evidence of haploinsufficiency. Kinetics of contraction and relaxation of myofibrils from a frozen left ventricular sample of the K280N HCM patient were compared to those of “control” myofibrils (from donor hearts, from aortic stenosis patients, and from HCM patients negative for sarcomeric protein mutations). Preparations, mounted in a force recording apparatus (15 °C), were maximally Ca2+-activated (pCa 4.5) and fully relaxed (pCa 9) by rapid (
- Published
- 2013
19. Increased tension cost in human familial hypertrophic cardiomyopathy caused by the MYH7 mutation R403Q
- Author
-
Nicoletta Piroddi, Beatrice Scellini, E. Rosalie Witjas-Paalberends, Ger J.M. Stienen, Corrado Pogessi, Jolanda van der Velden, and Chiara Tesi
- Subjects
medicine.medical_specialty ,Myofilament ,Contraction (grammar) ,business.industry ,Mutant ,Biophysics ,Anatomy ,Gene mutation ,Sarcomere ,Internal medicine ,medicine ,Cardiology ,media_common.cataloged_instance ,MYH7 ,European union ,business ,Myofibril ,hypertrophic cardiomyopathy ,cardiac muscle ,media_common - Abstract
Familial hypertrophic cardiomyopathy (HCM) is frequently caused by mutations in genes encoding sarcomeric proteins. Energy depletion of the heart is thought to initiate and promote HCM disease development. It has been hypothesized that HCM sarcomere gene mutations increase ATP utilization for myofilament contraction and thereby increase energy demand of the heart. Previous studies in single left ventricular myofibrils from myocardium harbouring the first identified causal HCM mutation R403Q in the gene encoding β-myosin heavy chain revealed increased rates of tension generation and relaxation in R403Q compared to myofibrils from healthy control myocardium. The altered kinetics observed in the mutant sample predicted a 3-fold increase in the energy cost of tension generation in R403Q sarcomeres. In the present study we investigated if tension cost was indeed increased in human myocardium harbouring the R403Q mutation.Maximal force generating capacity (Fmax) and ATP consumption (ATPmax) were simultaneously measured in Triton-permeabilized left ventricular muscle strips (n=8) from a patient carrying the R403Q mutation. Left ventricular muscle strips (n=17) from 5 HCM sarcomere mutation negative patients (HCMsmn) and strips (n=6) from 2 patients with secondary hypertrophy due to aortic stenosis (LVHao) served as a control groups. Economy of myofilament contraction is expressed as tension cost (TC), i.e. amount of ATP used during force development (ATPmax/Fmax). Both Fmax and ATPmax were significantly lower in R403Q compared to HCMsmn and LVHao. TC was significantly increased in R403Q (3.8±0.5 μmolL−1s−1/kNm−2) compared to HCMsmn and LVHao (1.6±0.1 and 1.7±0.1 μmolL−1s-1/kNm−2, respectively).Our data provide direct evidence that TC is increased in myocardium harbouring the MYH7 mutation R403Q, indicating that expression of R403Q in the heart impairs economy of myocardial contraction.Funding: Seventh Framework Program of the European Union “BIG-HEART,” grant agreement 241577
- Published
- 2013
20. Mechanical and energetic consequences of HCM-causing mutations
- Author
-
Cecilia Ferrantini, Corrado Poggesi, Beatrice Scellini, Alexandra Belus, Chiara Tesi, and Nicoletta Piroddi
- Subjects
Sarcomeres ,medicine.medical_specialty ,Myofilament ,Cardiomyopathy ,Pharmaceutical Science ,030204 cardiovascular system & hematology ,Biology ,Sarcomere ,03 medical and health sciences ,0302 clinical medicine ,Hypertrophic Cardiomyopathy, Myosin, Myosin Binding Protein-C, Cardiac Muscle ,Internal medicine ,Genetics ,medicine ,Cardiomyopathy, Hypertrophic, Familial ,Myocyte ,Animals ,Humans ,Genetic Predisposition to Disease ,Genetics (clinical) ,030304 developmental biology ,0303 health sciences ,Cardiac myocyte ,Hypertrophic cardiomyopathy ,Cardiac muscle ,Cardiomyopathy, Hypertrophic ,medicine.disease ,Myocardial Contraction ,Disease Models, Animal ,medicine.anatomical_structure ,Phenotype ,Mutation ,cardiovascular system ,Cardiology ,Molecular Medicine ,MYH7 ,Cardiology and Cardiovascular Medicine ,Energy Metabolism - Abstract
Hypertrophic cardiomyopathy (HCM) was the first inherited heart disease to be characterized at the molecular genetic level with the demonstration that it is caused by mutations in genes that encode different components of the cardiac sarcomere. Early functional in vitro studies have concluded that HCM mutations cause a loss of sarcomere mechanical function. Hypertrophy would then follow as a compensatory mechanism to raise the work and power output of the affected heart. More recent in vitro and mouse model studies have suggested that HCM mutations enhance contractile function and myofilament Ca(2+) sensitivity and impair cardiac myocyte energetics. It has been hypothesized that these changes may result in cardiac myocyte energy depletion due to inefficient ATP utilization and also in altered myoplasmic Ca(2+) handling. The problems encountered in reaching a definitive answer on the effects of HCM mutations are discussed. Though direct analysis of the altered functional characteristics of HCM human cardiac sarcomeres has so far lagged behind the in vitro and mouse studies, recent work with mechanically isolated skinned myocytes and myofibrils from affected human hearts seem to support the energy depletion hypothesis. If further validated in the human heart, this hypothesis would identify tractable therapeutic targets that suggest that HCM, perhaps more than any other cardiomyopathy, will be amenable to disease-modifying therapy.
- Published
- 2009
21. Life-Long Treatment with Late Sodium Current Blocker Reduces Myocardial Dysfunction and Remodeling in a Mouse Model of Hypertrophic Cardiomyopathy
- Author
-
Cecilia Ferrantini, Benedetta Tosi, Corrado Poggesi, Raffaele Coppini, Elisabetta Cerbai, Chiara Tesi, Beatrice Scellini, Manuel J. Pioner, Luca Mazzoni, Jill Tardif, Alessandro Mugelli, and Francesca Gentile
- Subjects
Inotrope ,Genetically modified mouse ,medicine.medical_specialty ,urogenital system ,business.industry ,fungi ,Biophysics ,Diastole ,Hypertrophic cardiomyopathy ,Ranolazine ,Left ventricular hypertrophy ,medicine.disease ,Endocrinology ,nervous system ,In vivo ,Fibrosis ,Internal medicine ,medicine ,sense organs ,business ,medicine.drug - Abstract
No drugs are capable to prevent phenotype development and adverse cardiac remodeling in hypertrophic cardiomyopathy (HCM). Ranolazine, a late Na+ current blocker, reduced arrhythmogenicity and improved relaxation in cardiomyocytes and trabeculae from HCM patients (Coppini et al., Circulation 2013). Employing a transgenic mouse model carrying the HCM-associated R92Q mutation in the TNNT2 gene, we previously showed that acute in vitro treatment with ranolazine is capable to reverse some electromechanical alterations, including the prolonged kinetics of Ca2+ transients, the higher diastolic [Ca2+] and the increased frequency of arrhythmogenic spontaneous activity (Pioner et al., Biophys J 2014, 106, 644a). Here we employed the same mouse model to assess whether long-term oral treatment with ranolazine since birth is capable to prevent the HCM phenotype and the associated myocardial remodeling. We compared the behavior of WT, R92Q-untreated and R92Q-treated 1 year old mice. Echocardiographic measurements showed that the R92Q-treated in vivo hearts lacked the left ventricular hypertrophy, hypercontractility and diastolic dysfunction found in the R92Q-untreated mice. Gadolinium-contrast magnetic resonance showed that the intramyocardial fibrosis of the R92Q-untreated hearts was largely reduced in the treated mice.Both amelioration of cardiomyocyte function and reduction of extracellular fibrosis may contribute to the positive effect of the long-term treatment with ranolazine that could represent a candidate for preventive treatment of phenotype-negative mutation carriers. Mechanical experiments in intact left and right ventricular trabeculae confirmed the alterations we had previously reported in R92Q-untreated mice compared to WT and showed that those alterations were mostly reversed in the R92Q-treated mice. In the R92Q-treated preparations the inotropic response to isoproterenol was preserved and the occurrence of spontaneous activity was markedly reduced compared to the untreated trabeculae and was comparable to that of WT trabeculae.
- Published
- 2015
22. Impaired diastolic function after exchange of endogenous troponin I with C-terminal truncated troponin I in human cardiac muscle
- Author
-
Jennifer E. Van Eyk, Nicoletta Piroddi, Beatrice Scellini, Cris dos Remedios, Alexandra Belus, R. Zaremba, D. Brian Foster, Nadiya A. Narolska, Corrado Poggesi, Kornelia Jaquet, Ger J.M. Stienen, A.M.C. Murphy, Jolanda van der Velden, Sascha Deppermann, Nicky M. Boontje, René J. P. Musters, Chiara Tesi, Physiology, and ICaR - Heartfailure and pulmonary arterial hypertension
- Subjects
Cardiac function curve ,Sarcomeres ,medicine.medical_specialty ,Physiology ,macromolecular substances ,Sarcomere ,Myofibrils ,Diastole ,Internal medicine ,Isometric Contraction ,Troponin I ,medicine ,Myocyte ,Humans ,Myocytes, Cardiac ,Sequence Deletion ,Pressure overload ,biology ,Troponin T ,Chemistry ,Cardiac muscle ,musculoskeletal system ,Troponin ,Cyclic AMP-Dependent Protein Kinases ,Myocardial Contraction ,Kinetics ,Endocrinology ,medicine.anatomical_structure ,biology.protein ,Cardiology ,cardiovascular system ,Cardiology and Cardiovascular Medicine - Abstract
The specific and selective proteolysis of cardiac troponin I (cTnI) has been proposed to play a key role in human ischemic myocardial disease, including stunning and acute pressure overload. In this study, the functional implications of cTnI proteolysis were investigated in human cardiac tissue for the first time. The predominant human cTnI degradation product (cTnI 1–192 ) and full-length cTnI were expressed in Escherichia coli , purified, reconstituted with the other cardiac troponin subunits, troponin T and C, and subsequently exchanged into human cardiac myofibrils and permeabilized cardiomyocytes isolated from healthy donor hearts. Maximal isometric force and kinetic parameters were measured in myofibrils, using rapid solution switching, whereas force development was measured in single cardiomyocytes at various calcium concentrations, at sarcomere lengths of 1.9 and 2.2 μm, and after treatment with the catalytic subunit of protein kinase A (PKA) to mimic β-adrenergic stimulation. One-dimensional gel electrophoresis, Western immunoblotting, and 3D imaging revealed that approximately 50% of endogenous cTnI had been homogeneously replaced by cTnI 1–192 in both myofibrils and cardiomyocytes. Maximal tension was not affected, whereas the rates of force activation and redevelopment as well as relaxation kinetics were slowed down. Ca 2+ sensitivity of the contractile apparatus was increased in preparations containing cTnI 1–192 (pCa 50 : 5.73±0.03 versus 5.52±0.03 for cTnI 1–192 and full-length cTnI, respectively). The sarcomere length dependency of force development and the desensitizing effect of PKA were preserved in cTnI 1–192 -exchanged cardiomyocytes. These results indicate that degradation of cTnI in human myocardium may impair diastolic function, whereas systolic function is largely preserved.
- Published
- 2006
23. Myopalladin knockout mice develop cardiac dilation and show a maladaptive response to mechanical pressure overload
- Author
-
Maria Carmela Filomena, Beatrice Scellini, Pierluigi Carullo, Marie Louise Bang, Mathias Gautel, Simona Nemska, Roman S. Polishchuk, Nicoletta Piroddi, Corrado Poggesi, Francesca D'Autilia, Chiara Tesi, Roman Medvedev, Roberta Crispino, Daniele Catalucci, Jianlin Zhang, Arianna Felicetta, Simone Serio, Wolfgang A. Linke, Daniel L. Yamamoto, and Andrea Ghisleni
- Subjects
Male ,Mouse ,SORBS2 ,Muscle Proteins ,Z-line ,030204 cardiovascular system & hematology ,Gene mutation ,Sarcomere ,0302 clinical medicine ,Connectin ,Myocytes, Cardiac ,Biology (General) ,Mice, Knockout ,0303 health sciences ,biology ,Chemistry ,General Neuroscience ,General Medicine ,medicine.anatomical_structure ,transaortic constriction ,cardiovascular system ,Medicine ,Titin ,Intercalated disc ,Research Article ,Cardiomyopathy, Dilated ,Sarcomeres ,medicine.medical_specialty ,QH301-705.5 ,Science ,Saccharomyces cerevisiae ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,Biochemistry and Chemical Biology ,Two-Hybrid System Techniques ,Internal medicine ,Pressure ,medicine ,Animals ,030304 developmental biology ,General Immunology and Microbiology ,Desmoplakin ,Myocardium ,Restrictive cardiomyopathy ,MYPN ,medicine.disease ,dilated cardiomyopathy ,Endocrinology ,Mutation ,biology.protein ,Calcium ,Mutant Proteins ,sarcomere ,knockout mice - Abstract
Myopalladin (MYPN) is a striated muscle-specific immunoglobulin domain-containing protein located in the sarcomeric Z-line and I-band. MYPN gene mutations are causative for dilated (DCM), hypertrophic, and restrictive cardiomyopathy. In a yeast two-hybrid screening, MYPN was found to bind to titin in the Z-line, which was confirmed by microscale thermophoresis. Cardiac analyses of MYPN knockout (MKO) mice showed the development of mild cardiac dilation and systolic dysfunction, associated with decreased myofibrillar isometric tension generation and increased resting tension at longer sarcomere lengths. MKO mice exhibited a normal hypertrophic response to transaortic constriction (TAC), but rapidly developed severe cardiac dilation and systolic dysfunction, associated with fibrosis, increased fetal gene expression, higher intercalated disc fold amplitude, decreased calsequestrin-2 protein levels, and increased desmoplakin and SORBS2 protein levels. Cardiomyocyte analyses showed delayed Ca2+ release and reuptake in unstressed MKO mice as well as reduced Ca2+ spark amplitude post-TAC, suggesting that altered Ca2+ handling may contribute to the development of DCM in MKO mice.
- Full Text
- View/download PDF
24. Impact of R4496C RyR2 Mutation on Myocardial Contractility
- Author
-
Raffaele Coppini, Chiara Tesi, Claudia Ferrara, Elisabetta Cerbai, Corrado Poggesi, Silvia G. Priori, Cecilia Ferrantini, Beatrice Scellini, and Francesca Stillitano
- Subjects
Inotrope ,medicine.medical_specialty ,Contraction (grammar) ,Chemistry ,Ryanodine receptor ,Biophysics ,chemistry.chemical_element ,Gating ,Calcium ,Ryanodine receptor 2 ,Contractility ,Endocrinology ,Internal medicine ,cardiovascular system ,medicine ,Myocyte - Abstract
Cardiac Ryanodine Receptor (RyR2) is a crucial determinant of Ca2+ availability in myofilament activation and force generation. To investigate the impact of RyR2 arrhythmia-related mutations on contractile function, atrial and ventricular trabeculae and ventricular myocytes from Wild Type (WT) and heterozygous R4496C RyR2 mutant (RyRR4496C+/-) mice were isolated and studied. Although under basal conditions contractility and Ca2+-transient amplitude are normal, RyRR4496C+/- preparations show reduced inotropic responses to high stimulation frequency, isoproterenol and other experimental interventions that potentiate contraction. The diminished inotropic response results from a smaller Sarcoplasmic Reticulum (SR) calcium load after inotropic stimulation than that of WT preparations. Moreover, RyRR4496C+/- muscles have faster mechanical restitution and shorter recovery of the amplitude of Ca2+release. In RyRR4496C+/- vs. WT myocytes sarcolemmal Ca2+-fluxes (ICa-L and INCX) and SR Ca2+-uptake are unchanged. We suggest that changes in gating of the mutant RyR2 Ca2+ channel are directly responsible for these observations. Fitting our experimental data for the R4496C mutation into a cardiomyocyte model, where the RyR2 gating properties are represented by a four state equilibrium and are modulated by luminal [Ca2+] ([Ca2+]SR), we predict an increase in sensitivity to [Ca2+]SR of both opening and closing channel transitions rates of mutant channels. Specifically, increasing [Ca2+]SR-sensitivity of closed-to-open transitions leads to SR-calcium depletion, blunted simulated inotropic responses and faster mechanical restitution. However, for the model to fully emulate our experimental results, [Ca2+]SR-sensitivity of open-to-closed transition also has to be increased, suggesting an effect of the R4496C mutation on RyR2-deactivation and Ca2+-release termination.
25. Tropomyosin Pseudo-Phosphorylation and Muscle Kinetics
- Author
-
Corrado Poggesi, Beata M. Wolska, Chiara Tesi, R. John Solaro, Beatrice Scellini, Marco S.L. Alves, Brandon J. Biesiadecki, David F. Wieczorek, Ganapathy Jagatheesan, Jonathan P. Davis, and Bin Liu
- Subjects
medicine.medical_specialty ,biology ,Chemistry ,Cardiac muscle ,Troponin T binding ,Biophysics ,macromolecular substances ,Tropomyosin ,Troponin ,Troponin C ,Endocrinology ,medicine.anatomical_structure ,Internal medicine ,medicine ,biology.protein ,medicine.symptom ,Myofibril ,Actin ,Muscle contraction - Abstract
Tropomyosin contains a phosphorylation site at Ser-283 located within the head-to-tail overlap region that regulates muscle contraction. Previously we demonstrated that recombinant wild-type (Tm-WT) and pseudo-phosphorylated (Tm-S283D) alpha tropomyosin, expressed and purified from insect cells, exhibit regulated ATPase activity and troponin T binding similar to that reported for non-phosphorylated and phosphorylated tropomyosin (pTm) purified from muscle. We further demonstrated transgenic mice expressing the pseudo-phosphorylated tropomyosin (Tm-S283D Tg) exhibit increased mortality and decreased rate of relaxation in the work performing heart preparation. These changes occur in the absence of altered steady state maximal force or calcium-sensitive force development in skinned papillary bundles. In light of these findings, we sought to investigate the effect of pTm on the kinetics of cardiac muscle function. Using an extraction/replacement protocol, we measured force kinetics in a myofibril preparation. Results demonstrate no significant difference between myofibrils replaced with Tm-S283D or Tm-WT in maximal force, the rate of force activation, or the rate of force redevelopment, implying pTm does not play a role in altering muscle activation or cycling kinetics. To investigate if pTm affects the kinetics of thin filament inactivation we measured the rate of calcium disassociation from troponin C. Results demonstrate thin filaments reconstituted with Tm-S283D decreased the rate of calcium disassociation from troponin C consistent with the previously observed relaxation impairment. Finally, to determine the effects of pTm on systemic alterations in cardiovascular performance we measured heart function in Tm-S283D Tg mice by echocardiography. Results demonstrate Tm-S283D Tg mice exhibit trends towards impaired cardiac contractility compared to non-transgenic mice including decreased peak systolic velocity and ejection fraction. Overall, these findings demonstrate tropomyosin phosphorylation contributes to the regulation of cardiac dynamics; however, the precise role of pTm in the development of cardiac dysfunction remains elusive.
- Full Text
- View/download PDF
26. The HCM-Associated Cardiac Troponin T Mutation K273N Accelerates Tension Generation and Relaxation in Human Cardiac Myofibrils
- Author
-
Corrado Poggesi, Nicoletta Piroddi, der Velden, Beatrice Scellini, Chiara Tesi, Jolanda van, Sabine J. van Dijk, Claudia Ferrara, Cecilia Ferrantini, and Cris dos Remedios
- Subjects
Heart transplantation ,0303 health sciences ,medicine.medical_specialty ,Contraction (grammar) ,Chemistry ,medicine.medical_treatment ,Mutant ,Biophysics ,Hypertrophic cardiomyopathy ,macromolecular substances ,Anatomy ,medicine.disease ,03 medical and health sciences ,0302 clinical medicine ,Troponin complex ,Mutant protein ,Internal medicine ,Cardiology ,medicine ,media_common.cataloged_instance ,European union ,Myofibril ,030217 neurology & neurosurgery ,030304 developmental biology ,media_common - Abstract
In spite of extensive work on the functional sequelae of Hypertrophic CardioMyopathy (HCM)-associated mutations in sarcomeric proteins, the mechanisms by which the mutant proteins cause the disease have not been definitely identified. Here we use the single myofibril technique (Tesi et al., Biophys. J., 2002, 83, 2142-2151) to compare the kinetics of contraction and relaxation of myofibrils isolated from frozen left ventricular samples of one homozygous HCM patient carrying the cardiac Troponin T (cTnT) mutation K273N (underwent heart transplantation) to those from “control” hearts. Preparations, mounted in a force recording apparatus (15 °C), were maximally Ca2+-activated (pCa 4.5) and fully relaxed (pCa 9) by rapid (
- Full Text
- View/download PDF
27. Impact of E163R cTnT Mutation on Cardiac Mechanics and Energetics in a Murine Model
- Author
-
Claudia Ferrara, Jill C. Tardiff, Beatrice Scellini, Salwa Abdullah, Sara Bardi, Nicoletta Piroddi, Cecilia Ferrantini, Josè Manuel Pioner, Benedetta Tosi, Corrado Poggesi, Coppini Raffaele, and Chiara Tesi
- Subjects
Genetically modified mouse ,0303 health sciences ,medicine.medical_specialty ,Contraction (grammar) ,Chemistry ,Mutant ,Biophysics ,Wild type ,Stimulation ,Anatomy ,musculoskeletal system ,03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,Troponin complex ,Internal medicine ,Myosin ,medicine ,Myofibril ,030217 neurology & neurosurgery ,030304 developmental biology - Abstract
Introduction: Many of cTnT mutations linked to cardiomyopathies fall the TNT1 domain/N terminal tail region of unresolved high definition structure. This region (∼94-170) of cTnT is critical to Tm binding and contraction regulation. Here, the impact of the E163R mutation in cTnT-TNT1 on contractile function and tension cost was investigated using intact and skinned preparations from WT and transgenic mouse hearts.Methods: Left and right ventricular trabeculae were dissected from non-transgenic wild type (WT) and heterozygous (Δ160E or E163R) mouse hearts and mounted isometrically to record twitch tension or, when skinned, Ca2+ activated force. Myofibrillar ATPase activity was measured by fluorimetric enzyme coupled assay (de Tombe and Stienen, 1995).Results: Myocardium of E163R mice shows: (i) no change of myosin isoform expression (ii) maintained peak isomentric twitch tension at all stimulation frequencies, (iii) prolonged time to peak and time to 50% relaxation, with preserved rate-adaptation of twitch duration, (iv) changes of the short-term interval force relationship and increased occurrence of spontaneous contractions. No significant differences were found in maximum Ca2+ activated tension of E163R and WT skinned trabeculae. However, Ca2+ sensitivity of tension was significantly increased in E163R skinned trabeculae when compared with WT. As to the economy of force maintenance, preliminary experiments suggest an increase of tension cost in trabeculae from E163R hearts. Resting ATPase activity also tended to be higher in E163R preparations. Kinetics of force development and relaxation will be assessed on single myofibrils, isolated from the same hearts.Conclusions: Both primary sarcomeric changes and secondary E-C coupling alterations contribute to mechanical impairment in E163R cTnT mutant myocardium. Supported by: EC Grant n. 241577 (BIG-Heart)
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.